Abrocitinib as a Novel Therapeutic Option for Elastolytic Giant Cell Granuloma: A Case Report

American Journal of Therapeutics · Published 2026-07-06 · DOI 10.1097/mjt.0000000000002180

Authors (2)

Xiao-Yu Wu, Bing-Jun Shi

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Wu, X., Shi, B. (2026). Abrocitinib as a Novel Therapeutic Option for Elastolytic Giant Cell Granuloma: A Case Report. American Journal of Therapeutics. https://doi.org/10.1097/mjt.0000000000002180

Related articles